RadNet, Inc. Common Stock (RDNT)
RadNet, Inc. (RDNT) is a leading provider of outpatient diagnostic imaging services in the United States. Established in 1984, the company operates numerous imaging centers, offering services such as MRI, CT, ultrasound, and mammography. RadNet focuses on delivering high-quality, accessible, and cost-effective imaging care, serving hospitals, outpatient clinics, and physicians. It aims to enhance patient outcomes through advanced technology and integrated care solutions.
Company News
RadNet, Inc. will present at the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9th, 2025, featuring key executives discussing the company's performance and strategy.
The global AI in healthcare market is projected to reach nearly $700 billion by 2034, growing at 38.5% annually. Companies are developing advanced AI diagnostic technologies targeting areas like diabetic retinopathy, cardiac screening, and chronic disease management, with increasing FDA approvals and commercial potential.
RadNet reported record Q2 2025 revenue of $498.2 million, exceeding analyst expectations, driven by advanced imaging procedures and digital health solutions. The company raised full-year 2025 guidance and demonstrated strong operational performance.
RadNet reported revenue of $459.71 million, up 13.9% year-over-year, and EPS of $0.16 in Q2 2024. The company's performance was mixed compared to analyst estimates.